tm logo
VENCLEXTA
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 14 Apr 2023

Last Applicant/ Owned by

1 North Waukegan Road

North Chicago

IL

60064

Serial Number

86560752 filed on 11th Mar 2015

Registration Number

5078740 registered on 08th Nov 2016

in the Principal Register

Correspondent Address

Cheryl A. Withycombe

Abbvie Inc

Mail code: AND-250C

18655 Teller Avenue

Irvine CA 92612

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

VENCLEXTA

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders


First Use Date in General

30th Apr 2016

First Use Date in Commerce

30th Apr 2016

Mark Details


Serial Number

No 86560752

Mark Type

No Service/Collective Mark

Attorney Docket Number

No ABVT68287

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
14th Apr 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
14th Apr 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
14th Apr 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05th Oct 2022TEAS SECTION 8 & 15 RECEIVED
08th Nov 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08th Nov 2016REGISTERED-PRINCIPAL REGISTER
05th Oct 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04th Oct 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
04th Oct 2016USE AMENDMENT FILED
04th Oct 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED